Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Sophie J. Bakri"'
Autor:
Prashant D. Tailor, MD, Timothy T. Xu, MD, Blake H. Fortes, MD, Raymond Iezzi, MD, Timothy W. Olsen, MD, Matthew R. Starr, MD, Sophie J. Bakri, MD, Brittni A. Scruggs, MD, PhD, Andrew J. Barkmeier, MD, Sanjay V. Patel, MD, Keith H. Baratz, MD, Ashlie A. Bernhisel, MD, Lilly H. Wagner, MD, Andrea A. Tooley, MD, Gavin W. Roddy, MD, PhD, Arthur J. Sit, MD, Kristi Y. Wu, MD, Erick D. Bothun, MD, Sasha A. Mansukhani, MBBS, Brian G. Mohney, MD, John J. Chen, MD, PhD, Michael C. Brodsky, MD, Deena A. Tajfirouz, MD, Kevin D. Chodnicki, MD, Wendy M. Smith, MD, Lauren A. Dalvin, MD
Publikováno v:
Mayo Clinic Proceedings: Digital Health, Vol 2, Iss 1, Pp 119-128 (2024)
Objective: To determine the appropriateness of ophthalmology recommendations from an online chat-based artificial intelligence model to ophthalmology questions. Patients and Methods: Cross-sectional qualitative study from April 1, 2023, to April 30,
Externí odkaz:
https://doaj.org/article/b989e4cca22a42128f8a8334faf81ad8
Publikováno v:
Ophthalmology and Therapy, Vol 12, Iss 5, Pp 2465-2477 (2023)
Abstract Introduction There is little understanding of long-term treatment persistence in patients receiving anti-vascular endothelial growth factor (anti-VEGF) injections for diabetic macular edema (DME), particularly relating to treatment intervals
Externí odkaz:
https://doaj.org/article/4f7e6530b3194476b5e57e26ad799de8
Autor:
Matthew R. Starr, Sophie J. Bakri
Publikováno v:
Journal of Ophthalmic & Vision Research, Vol 17, Iss 1, Pp 152-155 (2022)
Externí odkaz:
https://doaj.org/article/85c4ceffdd184ab2a5b5d7258e04de91
Autor:
Lauren A. Dalvin, Timothy W. Olsen, Sophie J. Bakri, Kristen McCullough, Ayalew Tefferi, Aref Al-Kali
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 26, Iss , Pp 101554- (2022)
Purpose: Myeloproliferative neoplasms (MPNs) have been associated with increased systemic levels of vascular endothelial growth factor (VEGF). This study investigated an association between systemic busulfan for treatment of MPN and the requirement f
Externí odkaz:
https://doaj.org/article/b81d98724d2245e4b922142cd502f1e9
Autor:
Tyler A. Bahr, Sophie J. Bakri
Publikováno v:
Life, Vol 13, Iss 5, p 1098 (2023)
Diabetic retinopathy (DR) is a microvascular disease caused by poorly controlled blood glucose, and it is a leading cause of vision loss in people with diabetes. In this review we discuss the current management of DR with particular focus on the use
Externí odkaz:
https://doaj.org/article/53d30f29cfe64e9fa0fa43af9014cadc
Autor:
Matthew R. Starr, Sophie J. Bakri
Publikováno v:
Journal of Ophthalmic & Vision Research, Vol 16, Iss 3, Pp 521-523 (2021)
Abstract Extremely thin sclera often necessitates abortion of scleral buckle procedures. In patients in whom a scleral buckle is desired, previous techniques have included the use of cyanoacrylate glue and continuing with surgery or placing donor tis
Externí odkaz:
https://doaj.org/article/ef063c30172741e89655661c410e3a60
Autor:
Vlad Diaconita, Heba Rihani, Virginia Mares, Marcio B. Nehemy, Sophie J. Bakri, Jose S. Pulido
Publikováno v:
International Journal of Retina and Vitreous, Vol 5, Iss 1, Pp 1-6 (2019)
Abstract Background Primary vitreoretinal lymphoma (VRL) is a rare disease with 30–380 new cases in the United States per year. Its insidious process and spread to the central nervous system (CNS) leads to a mean 5-year survival rate from 41.4 to 7
Externí odkaz:
https://doaj.org/article/160784f155cc455496cd96532b9e8b17
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 20, Iss , Pp 100904- (2020)
Purpose: Anti-vascular endothelial growth factor (VEGF) injections, while used to effectively treat numerous retinal vascular conditions, can be associated with transient and prolonged ocular hypertension. There is minimal literature detailing the de
Externí odkaz:
https://doaj.org/article/c4f13b8b75254d049a125441c3008e15
Publikováno v:
International Journal of Retina and Vitreous, Vol 4, Iss 1, Pp 1-4 (2018)
Abstract Background The ocular manifestations of cystic fibrosis typically present with surface irritation or nyctalopia due to Vitamin A deficiency, however, there have been two previous reports of patients with cystic fibrosis that developed retina
Externí odkaz:
https://doaj.org/article/0abf8ce461774cd1b947f992ae754591
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:S2-S11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4471b9153f673fbf1b6fb69ef8de07d5
https://doi.org/10.18553/jmcp.2023.29.5-a.s2
https://doi.org/10.18553/jmcp.2023.29.5-a.s2